We have not lifted any functions out of this paper's repositories yet, so there is nothing we have run. The repositories linked to it are listed below.
Some links come from the archived Papers with Code dataset (CC BY-SA 4.0): attribution and licence.
Design of new drug compounds with target properties is a key area of research in generative modeling. We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates: 1) a variational autoencoder-based approach (VAE) that uses prior knowledge of molecules that have been shown to be effective for earlier coronavirus treatments and 2) a deep Q-learning method (DQN) that generates optimized molecules without any proximity constraints. We evaluate the novelty of the automated molecule generation approaches by validating the candidate molecules with drug-protein binding affinity models. The VAE method produced two novel molecules with similar structures to the antiretroviral protease inhibitor Indinavir that show potential binding affinity for the SARS-CoV-2 protein target 3-chymotrypsin-like protease (3CL-protease).
The same record, over MCP at https://syntology.ai/mcp:
get_harvested_code_for_paper("2102.04977")
get_code_for_paper("2102.04977")
have("2102.04977")
The run record, dated, one paper per request, free:
curl https://syntology.ai/api/ran/2102.04977.json
A badge for a README (the split and the date, never a ratio):
[](https://syntology.ai/paper/2102.04977)
Connect an agent — have() is free.